Q1: What does Recovery Cat do?
A1: Recovery Cat is a digital mental health platform founded in Berlin that combines patient-facing symptom tracking with clinical decision support for healthcare teams. It focuses on severe psychiatric conditions such as schizophrenia, bipolar affective disorder, and major depression, using early warning algorithms to help prevent acute psychiatric relapses.
Q2: Why did Resilience Care acquire Recovery Cat in September 2026?
A2: Resilience Care acquired Recovery Cat to rapidly enter the German psychiatric market. Instead of building specialized clinical software and securing German hospital trial approvals from scratch, the acquisition gives Resilience an accredited, clinically validated platform built by Charité and Berlin Institute of Health researchers.
Q3: How will this acquisition affect psychiatric patients in Germany?
A3: Patients enrolled in partner clinics will see expanded access to integrated digital care plans, real-time medication management tools, and continuous outpatient connectivity. Resilience’s larger operational footprint will likely accelerate broader coverage agreements across German statutory health insurance funds.
